# US 2021/0246161 A1 · Methods of purifying proteins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0246161 A1
- Document ID: US20210246161A1
- Status: Published application
- Kind: A1
- Application number: 17/172,156
- Filed: 2021-02-10
- Published: 2021-08-12
- Earliest claimed: 2016-08-12
- Assignees: Bristol-Myers Squibb Company
- Applicants: Bristol-Myers Squibb Company
- Inventors: Zhengjian Li; Xuankuo Xu; Chao Huang; Zhiqiang Chen
- Web page: https://patentgrep.com/patent/US20210246161A1

## CPC

- C07K 1/18: Ion-exchange chromatography
- B01J 39/07: in the weakly acidic form
- B01J 39/20: obtained by reactions only involving unsaturated carbon-to-carbon bonds
- B01J 39/22: Cellulose or wood; Derivatives thereof
- C07K 1/22: Affinity chromatography or related techniques based upon selective absorption processes
- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K 2317/14: Specific host cells or culture conditions, e.g. components, pH or temperature
- C07K 2319/30: Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS

## Abstract

In some embodiments, the present invention provides a method of purifying a protein of interest with a reduced level of aggregation formation in cation exchange (CEX) chromatography, comprising: (a) providing a mixture comprising the protein of interest and one or more contaminants; (b) loading the mixture onto a CEX resin coupled with arginine; and (c) eluting the protein of interest from the resin, thereby purifying the protein of interest with a reduced level of aggregation formation in CEX chromatography.

## Claims

### Claim 1

A method of purifying a protein of interest with a reduced level of aggregation formation in cation exchange (CEX) chromatography, comprising:
(a) providing a mixture comprising the protein of interest and one or more contaminants;
(b) loading the mixture onto a CEX resin coupled with arginine; and
(c) eluting the protein of interest from the resin,
thereby purifying the protein of interest with a reduced level of aggregation formation in CEX chromatography.

### Claim 2 (depends on 1)

The method of claim 1, wherein the mixture comprises clarified bulk.

### Claim 3 (depends on 2)

The method of claim 2, wherein the clarified bulk comprises a cell culture supernatant.

### Claim 4 (depends on 3)

The method of claim 3, wherein the supernatant is from a mammalian, bacterial or fungal cell culture.

### Claim 5 (depends on 4)

The method of claim 4, wherein the supernatant is from a Chinese Hamster Ovary (CHO) cell culture.

### Claim 6 (depends on 1)

The method of claim 1, wherein the contaminants are selected from host cell proteins, host cell metabolites, host cell constitutive proteins, nucleic acids, endotoxins, viruses, product related contaminants, lipids, media additives and media derivatives.

### Claim 7 (depends on 1)

The method of claim 1, wherein the protein of interest is selected from an antibody, an antibody fragment, and an Fc fusion protein.

### Claim 8 (depends on 7)

The method of claim 7, wherein the protein of interest is an Fc fusion protein.

### Claim 9 (depends on 7)

The method of claim 7, wherein the antibody is a monoclonal antibody.

### Claim 10 (depends on 9)

The method of claim 9, wherein the monoclonal antibody is selected from the group consisting of a human, humanized and chimeric antibody.

### Claim 11 (depends on 1)

The method of claim 1, wherein the CEX resin is selected from agarose, cellulose, dextran, chitosan, poly(methacrylate), acrylic polymers, and poly(styrene-divinyl-benzene).

### Claim 12 (depends on 1)

The method of claim 1, wherein the CEX resin is prepared using a cation exchange ligand selected from sulfonate, carboxylic, carboxymethyl sulfonic acid, sulfoisobutyl, sulfoethyl, carboxyl, sulphopropyl, sulphonyl, sulphoxyethyl and orthophosphate.

### Claim 13 (depends on 1)

The method of claim 1, wherein the CEX resin coupled with arginine is an arginine-sulphopropyl (Arg-SP) functionalized resin.

### Claim 14 (depends on 1)

The method of claim 1, wherein the mixture is prepared by an affinity chromatography selected from a protein A affinity chromatography and a protein G affinity chromatography.

### Claim 15 (depends on 14)

The method of claim 14, wherein affinity chromatography is a protein A affinity chromatography.

### Claim 16 (depends on 1)

The method of claim 1, further comprising one or more additional chromatography matrixes.

### Claim 17 (depends on 16)

The method of claim 16, wherein the one or more additional chromatography matrices are selected from an anion exchange chromatography, a hydrophobic interaction chromatography, and a mix-mode chromatography.

### Claim 18

A cation exchange (CEX) resin coupled with arginine.

### Claim 19 (depends on 18)

The CEX resin of claim 18, wherein the CEX resin is selected from agarose, cellulose, dextran, chitosan, poly(methacrylate), acrylic polymers, and poly(styrene-divinyl-benzene).

### Claim 20 (depends on 18)

The CEX resin of claim 18, wherein the CEX resin is prepared using a cation exchange ligand selected from sulfonate, carboxylic, carboxymethyl sulfonic acid, sulfoisobutyl, sulfoethyl, carboxyl, sulphopropyl, sulphonyl, sulphoxyethyl and orthophosphate.

### Claim 21 (depends on 18)

The CEX resin of claim 18, wherein the CEX resin coupled with arginine is an arginine-sulphopropyl (Arg-SP) functionalized resin.
